Therapeutic Applications of Nano-Cardio-Nutraceuticals in Naturopathic Cardiovascular Care
Keywords:
Cardiovascular Disease, Therapeutic Applications, Nutrition, Heart Health, Cardio Nutraceuticals, Cardiovascular Care, NanoparticlesSynopsis
Cardiovascular diseases (CVDs) remain one of the leading causes of mortality worldwide, necessitating the development of safer, more effective, and holistic therapeutic approaches. In recent years, nutraceuticals derived from natural bioactive compounds have gained considerable attention for their cardioprotective potential in naturopathic healthcare systems. However, conventional nutraceutical formulations often suffer from poor bioavailability, low stability, limited absorption, and inadequate target specificity. The integration of nanotechnology with nutraceutical science has led to the emergence of nano-cardio-nutraceuticals, an advanced therapeutic platform designed to enhance the delivery, efficacy, and therapeutic performance of natural cardiovascular agents. This book chapter explores the therapeutic applications of nano-cardio-nutraceuticals in naturopathic cardiovascular care, emphasizing their role in the prevention, management, and supportive treatment of various cardiovascular disorders including hypertension, atherosclerosis, myocardial infarction, hyperlipidemia, ischemic heart disease, and oxidative stress-induced cardiac dysfunctions. The chapter discusses various nanoformulation strategies such as liposomes, solid lipid nanoparticles, nanoemulsions, polymeric nanoparticles, nanomicelles, dendrimers, and phytosomal systems for the encapsulation and targeted delivery of cardioprotective nutraceuticals including curcumin, resveratrol, quercetin, omega-3 fatty acids, coenzyme Q10, green tea polyphenols, garlic extracts, and other herbal bioactives. Special attention is given to the mechanisms by which nanocarrier systems improve solubility, controlled release, intestinal permeability, pharmacokinetics, and tissue targeting of nutraceutical compounds. Furthermore, the chapter highlights the synergistic integration of naturopathy and nanomedicine for personalized cardiovascular therapy, reduced adverse effects, and improved patient compliance. Current challenges, regulatory considerations, toxicity concerns, and future perspectives in the clinical translation of nano-cardio-nutraceuticals are also critically discussed. Overall, nano-cardio-nutraceuticals represent a promising frontier in modern naturopathic cardiovascular management, offering innovative opportunities for preventive cardiology and advanced therapeutic interventions through the convergence of natural medicine and nanotechnology.
Chapters
-
Introduction To Cardiovascular Disease: Global Burden, Risk Factor, And Therapeutics Gaps
-
Nutrition and Heart Health: Foundation for Cardio-Therapeutics
-
Cardio Nutraceuticals: Bioactive Compounds, Mechanism and Clinical Potential
-
Naturopathic Therapeutic in Cardiovascular Care
-
Fundamentals of Nanotechnology in Targeted Nutraceuticals Delivery
-
Nano emulsions for Cardiovascular Therapeutics
-
Liposomes, Phytosomes, and Niosomes for Nano-Targeted Cardio Nutraceuticals
-
Polymeric and Solid Lipid Nanoparticles in Cardiovascular Nano-Therapeutics
-
Antioxidant Nano-Targeted Therapeutics For Oxidative Stress Management in CVS
-
Anti-Inflammatory Nano Nutraceuticals in Targeted Cardiovascular Therapy
-
Synergistic Nano-Targeted Therapeutics with Naturopathic Interventions
-
Preclinical and Clinical Insights into Nano Targeted Cardio Nutraceuticals
-
Regulatory and Safety Challenges in Nano-Targeted Nutraceutical Development
-
Commercialization and Market Trends in Nano Cardio-Therapeutics
-
Smart Nano-Targeted Therapeutics for Cardiovascular Health: A Naturopathic Perspective
References
Farley, A., McLafferty, E., & Hendry, C. (2012). The cardiovascular system. Nursing Standard (Royal College of Nursing (Great Britain) : 1987), 27(9), 35–39. https://doi.org/10.7748/NS2012.10.27.9.35.C9383
Ference, B. A., Graham, I., Tokgozoglu, L., & Catapano, A. L. (2018). Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. Journal of the American College of Cardiology, 72(10), 1141–1156. https://doi.org/10.1016/j.jacc.2018.06.046
Fraioli, A., Serio, A., Mennuni, G., Ceccarelli, F., Petraccia, L., Fontana, M., Grassi, M., & Valesini, G. (2011). A study on the efficacy of treatment with mud packs and baths with Sillene mineral water (Chianciano Spa Italy) in patients suffering from knee osteoarthritis. Rheumatology International, 31(10), 1333–1340. https://doi.org/10.1007/S00296-010-1475-5
Gallucci, G., Tartarone, A., Lerose, R., Lalinga, A. V., & Capobianco, A. M. (2020). Cardiovascular risk of smoking and benefits of smoking cessation. Journal of Thoracic Disease, 12(7), 3866–3876. https://doi.org/10.21037/JTD.2020.02.47
Gokal, R., Shillito, L., & Maharaj, S. R. (2007). Positive impact of yoga and pranayam on obesity, hypertension, blood sugar, and cholesterol: a pilot assessment. Journal of Alternative and Complementary Medicine (New York, N.Y.), 13(10), 1056–1057. https://doi.org/10.1089/ACM.2007.0679
Gupta U, Kosey S, Pal R. Advancements in nanotechnology-based targeted drug delivery systems for glioblastoma chemotherapy: A comprehensive review. Journal of Drug Delivery Science and Technology. 2025 Sep 1;111:107181.
Haider, T., Sharma, M., & Branscum, P. (2017). Yoga as an Alternative and Complimentary Therapy for Cardiovascular Disease: A Systematic Review. Journal of Evidence-Based Complementary & Alternative Medicine, 22(2), 310–316. https://doi.org/10.1177/2156587215627390










